Northern Trust’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12M | Buy |
361,889
+8,285
| +2% | +$351K | ﹤0.01% | 1971 |
|
|
2025
Q4 | $16.4M | Sell |
353,604
-17,712
| -5% | -$741K | ﹤0.01% | 1800 |
|
|
2025
Q3 | $13M | Sell |
371,316
-9,471
| -2% | -$329K | ﹤0.01% | 1959 |
|
|
2025
Q2 | $11.3M | Sell |
380,787
-5,177
| -1% | -$148K | ﹤0.01% | 1998 |
|
|
2025
Q1 | $11.5M | Buy |
385,964
+807
| +0.2% | +$24.7K | ﹤0.01% | 1957 |
|
|
2024
Q4 | $11M | Buy |
385,157
+20,490
| +6% | +$678K | ﹤0.01% | 2063 |
|
|
2024
Q3 | $14.1M | Sell |
364,667
-4,884
| -1% | -$174K | ﹤0.01% | 1856 |
|
|
2024
Q2 | $11.9M | Sell |
369,551
-14,488
| -4% | -$502K | ﹤0.01% | 1895 |
|
|
2024
Q1 | $14.9M | Sell |
384,039
-16,828
| -4% | -$589K | ﹤0.01% | 1803 |
|
|
2023
Q4 | $12.3M | Sell |
400,867
-3,153
| -0.8% | -$79K | ﹤0.01% | 1927 |
|
|
2023
Q3 | $9.03M | Sell |
404,020
-2,436
| -0.6% | -$55.6K | ﹤0.01% | 2076 |
|
|
2023
Q2 | $8.73M | Buy |
406,456
+18,200
| +5% | +$413K | ﹤0.01% | 2160 |
|
|
2023
Q1 | $9.31M | Buy |
388,256
+3,065
| +0.8% | +$81.3K | ﹤0.01% | 2062 |
|
|
2022
Q4 | $8.94M | Sell |
385,191
-1,264
| -0.3% | -$25.5K | ﹤0.01% | 2083 |
|
|
2022
Q3 | $6.19M | Buy |
386,455
+4,053
| +1% | +$71.5K | ﹤0.01% | 2326 |
|
|
2022
Q2 | $6.78M | Sell |
382,402
-10,107
| -3% | -$170K | ﹤0.01% | 2308 |
|
|
2022
Q1 | $7.99M | Sell |
392,509
-14,704
| -4% | -$278K | ﹤0.01% | 2289 |
|
|
2021
Q4 | $7.61M | Sell |
407,213
-25,172
| -6% | -$491K | ﹤0.01% | 2429 |
|
|
2021
Q3 | $8.54M | Buy |
432,385
+23
| +0% | +$497 | ﹤0.01% | 2394 |
|
|
2021
Q2 | $10.2M | Sell |
432,362
-6,059
| -1% | -$140K | ﹤0.01% | 2344 |
|
|
2021
Q1 | $10.4M | Sell |
438,421
-18,532
| -4% | -$440K | ﹤0.01% | 2266 |
|
|
2020
Q4 | $9.15M | Sell |
456,953
-19,978
| -4% | -$390K | ﹤0.01% | 2307 |
|
|
2020
Q3 | $9.93M | Sell |
476,931
-17,520
| -4% | -$316K | ﹤0.01% | 2112 |
|
|
2020
Q2 | $8.65M | Buy |
494,451
+69,163
| +16% | +$1.35M | ﹤0.01% | 2187 |
|
|
2020
Q1 | $6.95M | Buy |
425,288
+8,311
| +2% | +$172K | ﹤0.01% | 2115 |
|
|
2019
Q4 | $8.58M | Sell |
416,977
-66,341
| -14% | -$1.11M | ﹤0.01% | 2272 |
|
|
2019
Q3 | $5.55M | Buy |
483,318
+95,878
| +25% | +$1.09M | ﹤0.01% | 2489 |
|
|
2019
Q2 | $5.09M | Buy |
387,440
+4,201
| +1% | +$56.2K | ﹤0.01% | 2550 |
|
|
2019
Q1 | $5.8M | Sell |
383,239
-50
| -0% | -$801 | ﹤0.01% | 2472 |
|
|
2018
Q4 | $6.58M | Sell |
383,289
-82,890
| -18% | -$1.42M | ﹤0.01% | 2334 |
|
|
2018
Q3 | $6.87M | Sell |
466,179
-60,320
| -11% | -$1.07M | ﹤0.01% | 2494 |
|
|
2018
Q2 | $12.6M | Buy |
526,499
+231,463
| +78% | +$5.69M | ﹤0.01% | 2119 |
|
|
2018
Q1 | $7.54M | Buy |
295,036
+7,553
| +3% | +$180K | ﹤0.01% | 2355 |
|
|
2017
Q4 | $5.31M | Buy |
287,483
+12,975
| +5% | +$186K | ﹤0.01% | 2562 |
|
|
2017
Q3 | $2.88M | Sell |
274,508
-3,917
| -1% | -$43.2K | ﹤0.01% | 2963 |
|
|
2017
Q2 | $3.48M | Buy |
278,425
+59,579
| +27% | +$589K | ﹤0.01% | 2839 |
|
|
2017
Q1 | $2.2M | Buy |
218,846
+3,383
| +2% | +$50.3K | ﹤0.01% | 3036 |
|
|
2016
Q4 | $3.35M | Buy |
215,463
+38,916
| +22% | +$647K | ﹤0.01% | 2804 |
|
|
2016
Q3 | $3.4M | Buy |
176,547
+5,079
| +3% | +$60.3K | ﹤0.01% | 2779 |
|
|
2016
Q2 | $2.03M | Buy |
171,468
+72,066
| +72% | +$1.19M | ﹤0.01% | 3017 |
|
|
2016
Q1 | $1.8M | Buy |
99,402
+15,267
| +18% | +$278K | ﹤0.01% | 3046 |
|
|
2015
Q4 | $2.31M | Buy |
84,135
+16,473
| +24% | +$347K | ﹤0.01% | 2975 |
|
|
2015
Q3 | $1.5M | Buy |
+67,662
| New | +$1.22M | ﹤0.01% | 3179 |
|
Other funds holding COLL
EAM
VCM
Northern Trust's COLL Position: Q1 2026 in Review
Northern Trust increased its Collegium Pharmaceutical (COLL) stake by 2.3% in Q1 2026, buying an estimated $351K and bringing the position to 361,889 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #1971.
Northern Trust first reported a position in COLL in Q3 2015 and has held it in 43 quarters since. The position peaked at $16.4M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- Northern Trust held 361,889 shares of Collegium Pharmaceutical worth $12M as of Q1 2026.
- Northern Trust bought 8,285 Collegium Pharmaceutical shares in Q1 2026, an estimated $351K.
- Collegium Pharmaceutical made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1971 holding.
- Northern Trust first reported a position in Collegium Pharmaceutical in Q3 2015 and has held it in 43 quarters since.
- Northern Trust's Collegium Pharmaceutical position peaked at $16.4M in Q4 2025.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.